Type Whole antibody Target IL23 CAS Number 1610353-18-8 | Source Human ATC code none ChemSpider none | |
Brazikumab (INN) is a human monoclonal antibody designed for the treatment of Crohn's disease.
This drug was developed by MedImmune.
References
Brazikumab Wikipedia(Text) CC BY-SA